4 associated with inhibition of antropyloric pressure waves, stimulation of isolated pyloric pressure waves and an increase in pyloric tone (4) .
The half life of GLP-1 in the plasma is short (1-2min.) as it is rapidly degraded by dipeptidyl peptidase IV and it is uncertain if the active peptide reaches all its receptors in an intact form (16, 17, 56, 6, 9, 43, 55, 63) . Therefore we hypothesize that it might have a local action in the ileum. The objectives of this study were to determine if GLP-1 acted on the canine ileum, a site at which it is released in the canine intestine, and to determine the site and nature of any such actions. 6 attached to record circular muscle contractions and electrodes pairs inserted 0.5-1cm below in cirumferential orientation.
Protocols:
In all cases, a recovery period of 30 minutes was followed by perfusion of increasing concentrations of acetylcholine, until a maximum response was attained. Other contractions were evaluated in terms of the percentage maximal response to acetylcholine. Acetylcholine was also infused intermittently and after completion of the experiment to ascertain that contractility remained unimpaired. If the response to a maximal dose was decreased to <80%, the experiment was discarded After a further rest period of [10] [11] [12] [13] [14] [15] min, the tissues were stimulated with electrical field stimulation (EFS) of the electrodes distal to the strain gauges (3 pps, 40V/cm, 0,5ms duration). In isolated segments, EFS was continued for 6 minutes, with a change in the polarity of the stimulating electrodes after 3 min. The two sets of electrodes (below the proximal and distal strain gauges) were each stimulated alternately for 6 min. throughout the experiment and data from both electrode sites was combined to study the time of affects of GLP-1. EFS was carried out initially until stable responses were obtained. GLP-1 infusions in physiological solution, by way of a T-tube in the intra-arterial cannnula, were found in preliminary experiments to have a delayed onset of action, partly due to the dead space in the perfusion tubing but mostly due to the inherent action of the agent. In experiments with close intra-arterial infusion, actions of GLP-1 were studied on responses to EFS as described above or on responses to repetitive infusions of a sub-maximal dose of acetylcholine (34 . The physiological solution contained (in mM): NaCl 115.5; NaHCO 3 21.9; KCl 4.6; MgSO 4 .7H 2 0 1.16; NaH 2 PO 4 .H 2 O; CaCl 2 2.5; glucose 11.1. ot was maintained at 37EC and bubbled with 95%O 2 -5%CO 2 .
Data Analysis: Records of the second minute of each recording at a given polarity of stimulation were analyzed (during the initial minute, contractile activities were unstable). Tonic tension data were analyzed as area under the contraction curve (AUC) as previously described (13) . Phasic tension increments were analyzed separately from tonic increments by summing each contraction during the second minute and 7 averaging the value. To obtain data on the duration of action of GLP-1, response from both proximal and distal electrodes and at both polarities of stimulation were combined. L-NOARG infusion increased tonic and phasic activity. The effect of L-NOARG on responses to GLP-1 was studied by evaluating the percentage decrease in the increment of activity caused by electrical field stimulation after L-NOARG to the percentage decrease in the increment before L-NOARG. 
Results:
In vivo GLP-1 caused marked inhibition of gastric emptying in dogs fed a saline meal. This resulted from increased pyloric tone and inhibition of propulsive antral contractions (4). Therefore we initially evaluated the effects of intra-arterial infusion of GLP-1 (0.1 to 100ng) into the antral and pyloric regions of anesthetized dogs at rest and during stimulation of enteric and vagal nerves as previously described (26,2).
There were no effects (data from 6 experiments, not shown). We also infused GLP-1 intravenously while activating enteric nerves, again without effect. These results shifted our focus to the ileum.
When GLP-1 (10 -11 mol to 10 -9 mol) was infused intra-arterially into the ileum (n=6) during stimulation from serosal electrodes placed 0.5 to 1 cm distal to the strain gauge over the perfused site (to elicit the ascending excitatory reflex), there was persistent inhibition of the phasic activity elicited by EFS ( Figure 1B at bottom) . A similar GLP-1 infusion had no significant effect on responses to acetylcholine given intra-arterially every two minutes. These studies (n=4) also showed that, under resting conditions,GLP-1 perfusions were without significant contractile effect ( Figure 1A at top). We observed that recovery of phasic activity in response to EFS after i.a. infusions of GLP-1 was delayed for long periods.
To understand the mechanisms involved, we used isolated arterially perfused ileal segments instrumented with two strain gauges, each with a distal pair of serosal electrodes, stimulated alternately as described in Methods. Infusion of GLP-1 inhibited responses to electrical field stimulation (EFS) of these electrodes applied alternately to the proximal and distal pair.. Figure 2 shows an example of the concentration-dependent (10 -8 M to 3x10 -7 M) effects of GLP-1 infusions. Infusions were carried out for 8 minutes and studied at least for 6 minutes after infusions were stopped on responses to EFS. Maximum inhibition was obtained with 10 -7 M GLP-1 (10 -9 M had no consistent effect). Figure 3 summarizes experiments of this type, demonstrating that GLP-1 primarily inhibited phasic but not tonic responses to EFS.
In order to define the duration of action of GLP-1, experiments were carried out using a concentration of 10 -7 M for 8 minutes. EFS was carried out alternately at both proximal and distal strain gauges and the effects were assembled ( Figures 4A and 4B ). The inhibition of phasic activity extended for greater than 22 minutes (more than 15 minutes after perfusion was stopped), while there were no consistent effects on tonic contractile activity..
Exendin (9-39) amide (3x10 -8 M) infused for 14 minutes before and during infusion of either 3x10 -8 or 10 -7 M GLP-1 had no ability to interfere with the inhibitory action of GLP-1 on phasic activity in response to EFS ( Figure 5 ). GLP-1 infused after exendin 9-39 had no effect on tone as usual (not shown). Exendin 9-39 itself had no effects on phasic responses to EFS ( Figure 6 ) or tonic responses (not shown)..
When TTX (10-20Fg) was infused and responses to EFS abolished, persistent phasic and tonic acitvity ensued as previously described (12, 34) . GLP-1 had no effect on this activity in concentrations through 3x10 -7 M (data not shown), indicating that it had no effect on myogenic activity, consistent with its lack of inhibitory effect on responses to intra-arterial acetylcholine. Perfusion of L-NOARG (10 -4 M) also induced persistent tonic and phasic activity, but responses to excitatory stimulation of proximal enteric nerves were preserved, as previously described 12 . GLP-1 had a reduced inhibitory effect on these responses, suggesting that NO release mediated its effects in part ( Figure 7 ), and the normalized results were significantly less reduced than in the same tissues perfused with GLP-1 before L-NOARG (p<0.03).
Capsaicin infused at 10 -6 or 3x10-6M had no effects on responses to EFS, but at 10 -5 M it like GLP-1 caused significant and persistent inhibition of phasic, but not tonic responses to EFS ( Figure 8 ). We attempted to achieve desensitization of responses to capsaicin, by subsequent infusions of capsaicin after an infusion of 10 -5 M, but we were unable to obtain persistent lack of effect to a subsequent infusion; i.e., when the phasic responses recovered sufficiently to test if GLP-1 could inhibit it, capsaicin was also capable of reducing it . After capsaicin, GLP-1 still causes inhibition of the residual phasic responses to EFS ( Figure   9 ), but the magnitude appeared to be less (non-significantly). There was no effect of GLP-1 on tone after capsaicin (not shown).
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Discussion:
The main findings of this study are that GLP-1 acts locally in the ileal region of the gastrointestinal tract near its release sites to inhibit activity of the enteric nervous system initiated by local activation of the ascending excitatory peristaltic reflex. Under the conditions of our experiments, using an isolated-perfused ileal segment, no extrinsic neural or hormonal influences are involved. GLP-1 causes concentrationdependent persistent inhibition of reflex neural activity, abolished by TTX, reduced by L-NOARG and without any effect on responses to exogenous acetylcholine.
The most surprising and interesting finding was that these effects of GLP-1 were unaffected by prior infusion of exendin (9-39) amide, an antagonist of the actions of GLP-1 at the known receptor (54). Thus our data as well as that of Nishizawa et al., (54) suggest that a neural receptor class for the action of GLP-1 may exist. One caveat is that we did not demonstrate that our exendin 3-39 was bioactive. In anesthetized animals there is no readily available test of bioactivity. Thus, although three different batches from the supplier, Bachem, behaved the same in our experiments, it is possible that they were not bioactive.
Another caveat is that we did not go to higher concentrations of exendin 3-39, because of the very high costs that would have resulted from perfusion before and during the exposure to GLP-1 in multiple experiments.
However, we believe that our concentrations were sufficient, at least, to affect the actions of GLP-1 based on reports in the literature (e.g., 54). Interestingly, the action of GLP-1, persistent inhibition of phasic activity, was mimicked by capsaicin in a concentration-dependent manner. Capsaicin may have reduced the inhibitory action of subsequent GLP-1, but it clearly did not abolish it and the change was not significant. Thus was probably because, under our conditions, we were unable to demonstrate persistent desensitization of responses to capsaicin; i.e., when the phasic responses to EFS recovered after capsaicin enough to test the inhibitory effects of GLP-1, the inhibitory response to capsaicin had also recovered.. Thus the interpretation of these results must be restrained. One suggestive evidence was that some L cells containing GLP-1 were near sites of immunoreactivity to the capsaicin receptor, presumably on sensory nerves (unpublished observations). 
